Login
$GENI
$6.32 -$0.20 (3.07%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2025
As of Dec 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q4 FY2020
As of Dec 31, 2020
ASSETS
Current assets:
Cash and cash equivalents
Restricted cash, current
Accounts receivable, net
Contract assets
Prepaid expenses
Other current assets
Total current assets
Property and equipment, net
Intangible assets, net
Operating lease right-of-use assets
Goodwill
Deferred tax asset
Investments
Restricted cash, non-current
Other assets
Total assets
LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS' EQUITY (DEFICIT)
Current liabilities:
Accounts payable
Accrued expenses
Deferred revenue
Current debt
Operating lease liabilities, current
Other current liabilities
Total current liabilities
Long-term debt – less current portion
Deferred tax liability
Operating lease liabilities, non-current
Other liabilities
Total liabilities
Shareholders' deficit
Common shares, Value
Ordinary B Shares
Common Stock Other Than B Shares
Additional paid-in capital
Treasury stock, at cost, 4,105,948 shares at December 31, 2025 and December 31, 2024
Accumulated deficit
Accumulated other comprehensive loss
Total shareholders' equity
Total liabilities and shareholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support